Study of the Anti-tumoral Immune Response
NCT02854644
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
167
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Glioma
Interventions
OTHER:
additional blood sample
Sponsor
Centre Hospitalier Universitaire de Besancon